key: cord-0790988-j7h632by
authors: Takemoto, Maira L.S.; Menezes, Mariane O.; Andreucci, Carla B.; Knobel, Roxana; Sousa, Liduína A.R.; Katz, Leila; Fonseca, Eduardo B.; Nakamura‐Pereira, Marcos; Magalhães, Claudia G.; Diniz, Carmen S.G.; Melo, Adriana S.O.; Amorim, Melania M.R.; Menezes, Mariane O.
title: Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID‐19 in Brazil: a surveillance database analysis
date: 2020-08-16
journal: BJOG
DOI: 10.1111/1471-0528.16470
sha: e377fc5feac71a222838b05a218528ffe2829f36
doc_id: 790988
cord_uid: j7h632by

OBJECTIVE: To describe clinical characteristics of pregnant and postpartum women with severe COVID‐19 in Brazil and to examine risk factors for mortality DESIGN: Cross‐sectional study based on secondary surveillance database analysis SETTING: Nationwide Brazil POPULATION OR SAMPLE: 978 Brazilian pregnant and postpartum women notified as COVID‐19 Acute Respiratory Distress Syndrome (ARDS) cases with complete outcome (death or cure) until June 18, 2020 METHODS: Data was abstracted from the Brazilian ARDS Surveillance System (ARDS‐SS) database. All eligible cases were included. Data on demographics, clinical characteristics, intensive care resources use and outcomes were collected. Risk factors for mortality were examined by multivariate logistic regression. MAIN OUTCOME MEASURES: Case fatality rate RESULTS: We identified 124 maternal deaths, corresponding to a case fatality rate among COVID‐19 ARDS cases in the obstetric population of 12.7%. At least one comorbidity was present in 48.4% of fatal cases compared to 24.9% in survival cases. Among women who died, 58.9% were admitted to ICU, 53.2% had invasive ventilation and 29.0% had no respiratory support. The multivariate logistic regression showed that the main risk factors for maternal death by COVID‐19 were postpartum at onset of ARDS, obesity, diabetes, and cardiovascular disease, while white ethnicity had a protective effect. CONCLUSIONS: Negative outcomes of COVID‐19 in this population are affected by clinical characteristics, but social determinants of health also seem to play a role. It is urgent to reinforce containment measures targeting obstetric population and ensure high quality care throughout pregnancy and postpartum period.

SARS-CoV-2. The disease rapidly spread worldwide and was declared a global pandemic on March 11 , 2020 by the World Health Organization (WHO). By July 20, 2020, COVID-19 had affected more than 14 million people in 188 territories, with more than 608,000 deaths. 1 Despite the incidence and mortality magnitude, how the infection impacts pregnancy or whether pregnancy and the postpartum period would lead to more vulnerability remain uncertain. 2, 3 Accepted Article This article is protected by copyright. All rights reserved Initial case series from China did not identify increased risk of adverse outcomes among obstetric patients when compared to the general population, as well as no maternal deaths were reported. 4, 5 However, physiological adaptations in normal pregnancies, mainly cardio-respiratory and immune, are known to increase the susceptibility of pregnant women to several infectious agents and viral pneumonia in particular 6 . Thus, clinicians worldwide remained worried about the impact of COVID-19 in this population. Subsequent data emerging from Europe and North America also concluded that pregnant women were at no increased risk of severe COVID-19 or death 3, 7, 8 . More recently, further studies reported higher risk of ICU admission and mechanical ventilation during pregnancy 9,10 , as well as the first near miss and maternal deaths cases emerged from Iran, US, UK, France, Mexico and Spain 7-9,11-16 . In Brazil, approximately two months after the first official COVID-19 case was reported, 1,700 deaths among the general population and five maternal deaths had already been documented, raising concerns that perhaps the pandemic in low-and middle-income countries could pose additional risks for pregnant women. 17 It was hypothesized that higher birth rates, worse population health status, and poor quality of obstetric care, now competing with constraints resulting from the pandemics management, would contribute to an increase in the absolute number of deaths and also in the case fatality rate. 17 The present analysis continues the initial investigations 17-19 of our group using data from the Brazilian Ministry of Health Acute Respiratory Distress Syndrome (ARDS) Surveillance System (ARDS-SS) to describe clinical characteristic and to examine risk factors for death among COVID-19 cases during pregnancy and the postpartum period in Brazil.

This is a secondary database, cross-sectional analysis of the ARDS-SS. Data were extracted from the ARDS-SS, which comprises mandatory notifications of all ARDS cases in the country, from both public and private units in all states. ARDS-SS was established in 2009, as a response to the H1N1 pandemic and specific fields to track pregnant and postpartum women has been available since then 20 . New specific fields were incorporated to the ARDS Notification Form to gather information on COVID-19 cases and are included in the database as well. Anonymized data is made publicly available by the Ministry of Health. Data was abstracted in June 18, 2020 and inclusion criteria were: i) pregnant or postpartum women; ii) confirmed (nasopharyngeal RT-PCR) SARS-CoV2 infection or confirmed COVID-19 case based on Brazilian Ministry of Health case Accepted Article definition; iii) final outcome (death or cure) recorded in the database; iv) registered from February 26 (date of the first COVID-19 case in the country) to June 18, 2020. We have been monitoring maternal deaths due to COVID-19 in Brazil since the beginning of the pandemic. We have published so far preliminary data on subsets of the present sample as they were available in each publication date [17] [18] [19] 21 , the last one including all 124 fatal cases notified until June 18, 2020, as well as 854 cases who evolved to cure 18 .

Besides ARDS-SS specific fields indicating whether a case is pregnant or in the postpartum period, we also hand-searched for mentions to pregnancy or postpartum in an open-ended field related to other comorbidities or risk factors. Information on gestational age or pregnancy outcome are not routinely collected by the ARDS-SS (only gestational trimester information is available).

A COVID-19 diagnosis was defined as the final classification of each case in the database according to the epidemiological investigation performed by the notifying unit. Figure 1 presents the case selection process, as well as the proportion of cases to whom a SARS-CoV-2 RT-PCR result was available. Among fatal cases, 95.2% had COVID-19 laboratory confirmation and 80.6% had SARS-CoV-2 RT-PCR results available (serological antibodies and rapid test were recorded for the other cases). These proportions were 97.4% and 78.7%, respectively, among survivors.

The main outcome was COVID-19 case fatality rate among ARDS-cases in pregnant and postpartum women and the following variables were analyzed for each case: age, ethnicity, pregnancy or postpartum status at notification date, gestational trimester at notification date (for pregnant cases), comorbidities (diabetes, cardiovascular disease, asthma, obesity), ICU admission and respiratory support requirement. Pregnancy or postpartum status and gestational trimester at notification date were assumed to be a proxy of symptoms onset timing, once the Notification Form collecting this information is usually filled in upon hospital admission due to ARDS.

Comorbidity-related ARDS-SS fields do not allow identification of gestational or pre-gestational diabetes and hypertension and did not separate heart diseases from hypertensive disorders; thus, these conditions are grouped under "diabetes" and "cardiovascular disease" variables. For the present analysis, we interpreted missing data as absence of the specific condition or characteristic.

This assumption was applicable to comorbidities, ICU admission and respiratory support. Overall missingness for comorbidities on ARDS-SS was previously described by Baqui et al for the general population 22 and by Takemoto et al 18 for the obstetric population.

This article is protected by copyright. All rights reserved Core outcome sets and patient involvement requirements are not applicable to this analysis due to its retrospective, secondary database nature. Brazilian ethical regulations do not require Institutional Review Board approval for secondary anonymized data analysis.

Sample size calculation was not performed once we included all eligible cases from the nationwide ARDS-SS database. STATA 12 was used for statistical analyses. Continuous variables were described using measures of central tendency and dispersion and compared using the Mann-Whitney test. Categorical variables were described using measures of frequency and compared by exact Fisher's and Chi-squared test. Multiple logistic regression with a simultaneous entry method was used to explore association of demographic and clinical characteristics with risk of death.

Variables with statistically significant differences in hypothesis tests were selected to enter the model (age data was dichotomized as ≤ or > 35 years). Statistical significance level was set at 0.05 and all p-values were two-tailed.

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

We identified 978 COVID-19 cases in pregnant or postpartum women in the ARDS-SS with recorded outcome. The case fatality rate among women with COVID-19 ARDS during pregnancy and postpartum was 12.7% (124 deaths). Figure 2 illustrates the distribution of cases within the country with most cases occurring in São Paulo (SP, n=359), Rio de Janeiro (RJ, n=107), Ceará (CE, n=106), and Amazonas (AM, n=92). Mortality rate among COVID-19 maternal ARDS cases in these states were: 14.1%, 9.4%, 29.0%, and 5.8% (data not shown).

Demographic and clinical characteristics of fatal and non-fatal cases are shown in Table 1 . Nonsurvivors were older and symptoms onset occurred more frequently in postpartum. At least one comorbidity was present in 48.4% of fatal cases compared to 24.9% in survival cases, and the most common was cardiovascular disease, followed by diabetes. Among women who died, 58.9% were admitted to ICU, 53.2% had invasive ventilation and 29.0% had no respiratory support.

The multivariate logistic regression showed that the main risk factors for maternal death by COVID-19 were postpartum at onset of ARDS (OR=2.48; 1.65-3.72), obesity (OR=2.31; 1.10-

This article is protected by copyright. All rights reserved 4.84), diabetes (OR=1.82; 1.01-3.28) and cardiovascular disease (OR=1.74; 1.02-2.94), while white ethnicity had a protective effect (OR=0.58; 0.35-0.99) ( Table 2) .

We identified 978 maternal cases of ARDS and 124 maternal deaths due to COVID-19 in Brazil.

Women in our sample were generally young, and the age difference between survivors and nonsurvivors was only 2 years although statistically significant. Besides, a significant proportion (51.6%) of women who died from COVID-19 had no comorbidities or risk factors recorded in the ARDS-SS database. This seems to indicate that apparently young and healthy women have died due to COVID-19 complications during pregnancy or just after birth. Among those who had comorbidities, the most common condition was cardiovascular disease followed by diabetes.

Similar findings have been documented in a systematic review with non-pregnant subjects. 23 In our sample, 41.1% of women were not admitted to the ICU and 29.0% did not have records of any type of respiratory support. These findings may indicate that barriers to access intensive care may be playing a role in the overwhelming number of COVID-19 maternal deaths in Brazil. A US Center for Disease Control report examining more than 8,000 pregnant women with COVID-19 and 16 cases of maternal deaths identified an increased risk of hospital admission, admission to the ICU and mechanical ventilation in pregnant women, although there was no higher risk of death 9 . Similar findings were also described in Sweden 10 , demonstrating that pregnant women may be more susceptible to COVID-19 complications, but with adequate and timely intensive care the survival rate could be similar to non-pregnant women.

Obstetric cases of ARDS due to COVID-19 in Brazil are at an increased risk of death if symptoms onset occurs during the postpartum period, they had obesity, diabetes, or cardiovascular disease.

Similarly, an analysis from Mexico 24 identified that having a comorbidity, particularly diabetes, increases the risk of death among pregnant women with COVID-19. In our sample, being White was protective against death. Previous finds from UK and US have indicated that pregnant women from ethnic minority groups are at increased risk of adverse outcomes 8, 9 . Similar findings were expected in Brazil, where racial disparities in the access to health care are well documented. 25

This article is protected by copyright. All rights reserved Our study is secondary data analysis of an official nationwide database. In Brazil, ARDS cases due to any cause have been considered of mandatory notification to the Ministry of Health since 2009 and the specific aetiology is recorded, as well as the diagnostic method. Both aspects contribute to the robustness of our analysis in terms of nationwide representativeness and to the higher rate of laboratory-confirmed SARS-CoV-2. Additionally, our findings about risk factors for death are consistent with a previous report from Mexico 24 and also with analysis for the general population 23, 26 . It is important to highlight that the available data refer to COVID-19 ARDS cases only and that we do not have information on non-ARDS COVID-19 cases in the obstetric population systematically collected in the country. Also, underreporting of maternal deaths is a recognized issue in the country. 27

According to our findings, the number of COVID-19-related maternal deaths is up to now surpassing the published available combined figures from other countries 28 

This article is protected by copyright. All rights reserved Currently, the first cause of maternal death and near miss in Brazil is hypertension 29, 31 , and inflammatory states have been described as relevant etiological hypothesis for both hypertension and preeclampsia. 32 Thus, when hypertension and COVID-19 simultaneously occur, it is possible to conjecture that inflammatory response may play a role in worsening prognosis, especially during pregnancy. Another possible explanation may be a combination of the country's high prevalence of overweight and obesity with metabolic syndrome, 33 considering the same inflammatory aspect of immune system response to coronavirus. Obesity was associated with antepartum severe maternal morbidity and may contribute to maternal deaths due its association with preeclampsia 34, 35 .

The prioritization of COVID-19 cases through the health care systems have been described as impacting maternal and neonatal outcomes worldwide. 36 In Brazil, even before the COVID-19 global pandemic, access to antenatal care faced chronic and complex barriers. 25, 37 Therefore, barriers to access routine assessment and testing may lead to delays in receiving proper care, potentially contributing to maternal deaths. Additionally, Brazilian caesarean rates are historically high and local data evidenced a three times higher risk of maternal death associated with caesarean sections. 38 In the pandemic context, at least one study already raised awareness of increased risk of adverse and/or severe features of COVID-19 disease for patients undergoing surgeries. 39 The disquieting findings about maternal deaths due to COVID-19 in Brazil are worrisome, since the country was not able to control the pandemic and the number of new cases and deaths are still rising. Our data highlights the urgent need for containment measures aimed to the obstetric population, particularly women with high-risk pregnancies and postpartum women. These measures should include timely and detailed analysis of each COVID-19-related maternal death along with COVID-19-related maternal near misses (the latter not even auditable through Brazilian health information system). . This might allow producing guidelines and local strategies to improve patients' journey specifically designed for COVID-19 during pregnancy and postpartum, to enhance maternal and perinatal outcomes.

A call for action in April 2020 already anticipated that women during pregnancy and postpartum might be a vulnerable population for COVID-19 not only due to biological or clinical factors, but also due to social risks. 40 We believe that Brazil is currently facing the tragedy of the aforementioned prediction, and that estimating its real dimension can contribute to reverse the present disaster.

This article is protected by copyright. All rights reserved CONCLUSION COVID-19-related maternal deaths in Brazil surpassed worldwide combined published figures.

Negative outcomes of COVID-19 in this population are affected by clinical characteristics, but social determinants of health and barriers to access proper care seem to play a role. It is urgent to reinforce containment measures targeting the obstetric population and ensure high quality care throughout pregnancy and the postpartum period.

We declare no competing interests. Completed disclosure of interest forms are available to view online as supporting information.

The authors would like to thank all members of the Brazilian Group for Studies of COVID-19 and pregnancy for all efforts in supporting this work.

MLST contributed for study conception and study design, conducted literature search and data extraction, conducted data analysis and interpretation, wrote the first draft of the paper, reviewed and approved the final manuscript.

MOM contributed for study conception and study design, conducted literature search and data extraction, conducted data analysis and interpretation, wrote the first draft of the paper, reviewed and approved the final manuscript.

CAB contributed for study conception and study design, conducted data analysis and interpretation, reviewed and provided comments on the first draft, reviewed and approved the final manuscript.

RK contributed for study conception and study design, conducted data analysis and interpretation, reviewed and provided comments on the first draft, reviewed and approved the final manuscript.

LARS contributed for study conception and study design LK contributed for study conception and study design, reviewed and approved the final manuscript.

EBF contributed for study conception and study design, reviewed and approved the final manuscript.

This article is protected by copyright. All rights reserved MNP contributed for study conception and study design, conducted data analysis and interpretation, reviewed and provided comments on the first draft, reviewed and approved the final manuscript.

CGM contributed for study conception and study design, reviewed and approved the final manuscript.

CSGD contributed for study conception and study design, reviewed and approved the final manuscript.

ASOM contributed for study conception and study design, conducted literature search and data collection, conducted data analysis and interpretation, wrote the first draft of the paper, reviewed and approved the final manuscript.

MMRA contributed for study conception and study design, wrote the first draft of the paper, reviewed and approved the final manuscript.

According to Brazilian ethics regulatory requirements, secondary analysis of publicly available anonymized data does not require Institutional Review Board ethics approval.

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

This article is protected by copyright. All rights reserved 

World Health Organization (WHO)

Effects of Coronavirus Disease 2019 (COVID-19) on Maternal, Perinatal and Neonatal Outcomes: a Systematic Review of 266 Pregnancies. medRxiv

Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: A systematic review. medRxiv

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Accepted Article 5

Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases

The impact of influenza virus infection in pregnancy

COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK a national cohort study using the UK Obstetric Surveillance System (UKOSS)

Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States

Pregnant and postpartum women with SARS-CoV-2 infection in intensive care in Sweden

Maternal Mortality Among Women with COVID-19 Admitted to the Intensive Care Unit

Maternal Death Due to COVID-19 Disease

Maternal mortality from COVID-19 in Mexico

A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States

A snapshot of the Covid-19 pandemic among pregnant women in France

All rights reserved C, Llana Martín I, et al. Multi-centre Spanish study found no incidences of viral transmission in infants born to mothers with COVID-19

Maternal Deaths with Covid19: a different outcome from mid to low resource countries?

The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting

Maternal mortality and COVID-19

Secretaria de Vigilância em Saúde. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Influenza

Disproportionate impact of COVID-19 among pregnant and postpartum Black Women in Brazil through structural racism lens

Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Risk factors for mortality in pregnant women with SARS-CoV-2 infection. medRxiv

The color of pain: racial iniquities in prenatal care and childbirth in Brazil

Obesity and impaired metabolic health in patients with COVID-19

Accepted Article This article is protected by copyright. All rights reserved Estimation of maternal mortality rates in Brazil

Worldwide maternal deaths due to COVID-19: A brief review

Departamento de Informática

Editorial COVID-19 in Brazil : "So what?

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn

The role of inflammation in the pathology of preeclampsia

Maternal anthropometry: trends and inequalities in four population-based birth cohorts in Pelotas, Brazil

The association between body mass index and preeclampsia: a metaanalysis

Associations between maternal obesity and severe maternal morbidity: Findings from the French EPIMOMS population-based study

SARS-CoV-2 Infection in Pregnancy -a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome

Avaliação da adequação da assistência pré-natal na rede SUS do Município do Rio de Janeiro, Brasil. Cad Saude Publica

Bouvier-Colle Accepted Article This article is protected by copyright. All rights reserved MH, Do Carmo Leal M. Caesarean delivery and postpartum maternal mortality: A population-based case control study in Brazil

Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Chen

A call for action for COVID-19 surveillance and research during pregnancy

Accepted Article